Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Statement of Cash Flows [Abstract]
Net loss	$ (27,280)	$ (941)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for (recovery of) bad debts	510	(551)
Deferred tax expense	(19,984)	(538)
Depreciation and amortization	47,579	12,964
Amortization of debt discount and issuance costs	3,286	5,118
Equity-based compensation	7,472	9,467
Contingent consideration	(5,409)	135
Warranty provision	1,215	425
Provision for inventory obsolescence	409	1,236
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(106,548)	(30,393)
Inventories	(77,191)	(20,443)
Income tax receivables	(7,062)	9,236
Prepaid expenses and other	(376)	826
Accounts payable	74,645	(1,378)
Accounts payable - related party	(132)	(1,622)
Accrued expenses and other	3,356	(10,541)
Income tax payable	(7,217)	(8,814)
Lease liabilities	4,700	68
Deferred revenue	47,263	(98,363)
Net cash used in operating activities	(60,764)	(134,109)
Cash flows from investing activities
Purchase of property, plant and equipment	(3,895)	(1,200)
Acquisition of STI, net of cash acquired	(373,818)	0
Investment in equity security	0	(11,975)
Net cash used in investing activities	(377,713)	(13,175)
Cash flows from financing activities
Proceeds from Series A issuance	33,098	0
Proceeds from common stock issuance	15,885	0
Series A equity issuance costs	(575)	0
Common stock issuance costs	(450)	0
Payments on revolving credit facility	(33,000)	0
Proceeds from issuance of other debt	30,599	0
Proceeds from revolving credit facility	101,000	102,000
Principal payments on debt	(22,377)	(31,075)
Contingent consideration	(1,483)	(7,810)
Debt issuance costs	0	(6,590)
Net cash provided by financing activities	122,697	56,525
Effect of exchange rate changes on cash and cash equivalent balances	(844)	0
Net change in cash and cash equivalents	(316,624)	(90,759)
Cash and cash equivalents, beginning of period	367,670	108,441
Cash and cash equivalents, end of period	51,046	17,682
Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$ 200,224	$ 0